Načítá se...
Structure-based in silico approaches for drug discovery against Mycobacterium tuberculosis
Mycobacterium tuberculosis is the causative agent of TB and was estimated to cause 1.4 million death in 2019, alongside 10 million new infections. Drug resistance is a growing issue, with multi-drug resistant infections representing 3.3% of all new infections, hence novel antimycobacterial drugs are...
Uloženo v:
| Vydáno v: | Comput Struct Biotechnol J |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Research Network of Computational and Structural Biotechnology
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8258792/ https://ncbi.nlm.nih.gov/pubmed/34285773 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.csbj.2021.06.034 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|